566 Results
Sort By:
Published on May 11, 2018
Machine learning and artificial intelligence (AI) are prominent buzzwords when the topic of precision medicine comes up, but like many emerging technologies with the potential to make a significant impact, it can be difficult sometimes to separate the hype from the real-world impact. AI entered that breathless, overhyped territory last…
Published on April 12, 2018
St. Jude Children’s Research Hospital has launched St. Jude Cloud, a data-sharing and platform available to researchers around the world that that St. Jude is calling the world’s largest public repository of pediatric cancer genomics data. The repository was built in collaboration with DNAnexus and Microsoft, which provide researchers with data-mining, analysis,…
Published on April 7, 2018
Digging deeper than previous cancer genomic studies, the PanCancer Initiative has released an analysis of 33 types of cancer across more than 10,000 patients. The new analysis shows that all 33 cancer types, based on their cellular and genetic makeup and independent of their anatomic site of origin, could be…
Published on April 4, 2018
Approximately 40 percent of Phase III clinical trials end in failure. By some estimates, that rate could be cut in half by the use of genomic data to select better drug targets in the first place. The problem, however, is that pharmaceutical companies lack access to large genomic databases that…
Published on March 13, 2018
Qiagen and Natera are partnering to develop cell-free DNA assays focused on prenatal screening for Qiagen’s GeneReader NGS System, through a 10-year collaboration that could generate up-to-$50 million-plus for Natera. In interviews, executives from the companies said their partnership is designed to build on Natera’s expertise in reproductive genetics and…
Published on March 9, 2018
Prof. John Mattick, Ph.D., a global genomics pioneer who has served as executive director of Australia’s Garvan Institute of Medical Research since 2012, has been appointed the first CEO of Genomics England, the U.K. Department of Health entity created to run the 100,000 Genomes Project. Mattick will assume executive responsibilities…
Published on March 2, 2018
The NIH is partnering with Inova Health System to launch a two-year pilot project designed to connect researchers to individuals with genotypes of interest and examine the genes and gene variants’ influence on their phenotypes. Through The Genomic Ascertainment Cohort (TGAC), the NIH plans to establish a new database of 10,000…
Published on February 26, 2018
PerkinElmer has agreed to acquire RHS for A$25.2 million ($19.7 million), in a deal that expands the buyer’s genomic research offerings with the Australian company’s single-cell genomics technologies. RHS’ technologies include DOPlify, a platform for whole genome amplification of single or small numbers of cells intended for the global next-generation…
Published on February 26, 2018
Studies by researchers in Sweden suggest that one of the reasons our muscles lose strength and function as we age may be because the stem cells that build and regenerate muscle tissue accumulate huge numbers of gene mutations. The Karolinska Institutet team, headed by Maria Eriksson, Ph.D., a professor in…
Published on February 15, 2018
Few scientists earn a repeat invitation to keynote the Molecular Medicine Tri-Con (TRICON) event, especially not 23 years apart. But Lee Hood is an exception. Kicking off the 25th anniversary edition of TRICON in San Francisco earlier this week, Hood reflected on his mission to promote “P4 medicine”, illustrating with…
Published on January 25, 2018
sing an unusual approach that combines linkage analysis, whole–genome sequencing (WGS), and biological studies, researchers have found evidence for a new genetic variant (in the gene RAB10) that may be protective against Alzheimer’s disease (AD). Scientists at Brigham Young University (BYU), led by John S. Kauwe, Ph.D., published results of…
Published on January 25, 2018
David Atkins, Ph.D., a veteran of healthcare and diagnostics businesses with experience stretching more than 25 years, has been appointed CEO of Congenica, a provider of clinical genomics interpretation software. Based in Cambridge, U.K., at the Welcome Genome Campus, Congenica has developed the clinical genomics analysis platform Sapientia, designed to…
Published on January 22, 2018
IntegraGen has launched two separate software-as-a-service (SaaS) tools designed to solve complex queries based on large-scale genomic data in real time, with the goal of assisting in patient diagnosis and management. Sirius and Mercury combine high-performance computing power via technologies based on serverless big data analytics platforms and powerful search…
Published on January 12, 2018
Thermo Fisher Scientific recently launched a new benchtop line of next-generation sequencing instruments (NGS) called the Ion GeneStudio S5 Series—including the new Ion 550 chip—which features read lengths of up to 600 base pairs and houses five Ion S5 chips that can provide for flexibility across many different research applications.…
Published on January 10, 2018
Mayo Clinic announced separate business agreements in two corners of the world on Jan. 8 and 9 to help commercialize and develop novel diagnostics in China and to integrate whole-genome sequencing in its clinical setting for healthy patients. In the first agreement, Mayo Medical Laboratories has entered a joint venture…